2013 Q1 Form 10-K Financial Statement
#000104746913006422 Filed on May 23, 2013
Income Statement
| Concept | 2013 Q1 | 2013 | 2012 Q1 |
|---|---|---|---|
| Revenue | $163.4M | $575.5M | $130.5M |
| YoY Change | 25.23% | 47.59% | 155.38% |
| Cost Of Revenue | $47.99M | $134.3M | $51.10M |
| YoY Change | -6.08% | 5.27% | 302.36% |
| Gross Profit | $115.4M | $298.6M | $79.40M |
| YoY Change | 45.38% | 13.8% | 106.77% |
| Gross Profit Margin | 70.63% | 51.88% | 60.84% |
| Selling, General & Admin | $34.68M | $116.6M | $38.80M |
| YoY Change | -10.62% | -15.28% | 60.33% |
| % of Gross Profit | 30.04% | 39.05% | 48.87% |
| Research & Development | $35.80M | $128.1M | $45.20M |
| YoY Change | -20.8% | -9.72% | 62.59% |
| % of Gross Profit | 31.01% | 42.9% | 56.93% |
| Depreciation & Amortization | $18.32M | $31.90M | $20.60M |
| YoY Change | -11.06% | -33.38% | 724.0% |
| % of Gross Profit | 15.87% | 10.68% | 25.94% |
| Operating Expenses | $70.48M | $283.1M | $95.60M |
| YoY Change | -26.28% | 1.28% | 83.85% |
| Operating Profit | $18.98M | $81.81M | -$16.20M |
| YoY Change | -217.19% | -192.67% | 19.12% |
| Interest Expense | $11.47M | -$9.700M | -$9.800M |
| YoY Change | -217.07% | -134.51% | -1733.33% |
| % of Operating Profit | 60.44% | -11.86% | |
| Other Income/Expense, Net | -$11.12M | -$46.37M | -$300.0K |
| YoY Change | 3606.0% | 77.6% | |
| Pretax Income | $7.866M | $35.44M | -$67.80M |
| YoY Change | -111.6% | -130.98% | 417.56% |
| Income Tax | $4.867M | $10.46M | -$4.400M |
| % Of Pretax Income | 61.87% | 29.51% | |
| Net Earnings | $3.000M | $24.98M | -$63.40M |
| YoY Change | -104.73% | -0.07% | 383.97% |
| Net Earnings / Revenue | 1.84% | 4.34% | -48.58% |
| Basic Earnings Per Share | $0.02 | ||
| Diluted Earnings Per Share | $0.02 | $121.4K | -$487.7K |
| COMMON SHARES | |||
| Basic Shares Outstanding | 133.3M shares | 131.7M shares | 129.7M shares |
| Diluted Shares Outstanding | 139.7M shares | 137.1M shares |
Balance Sheet
| Concept | 2013 Q1 | 2013 | 2012 Q1 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $221.4M | $362.2M | $190.4M |
| YoY Change | 16.23% | 63.6% | -5.4% |
| Cash & Equivalents | $96.96M | $167.6M | $83.60M |
| Short-Term Investments | $124.4M | $194.7M | $106.8M |
| Other Short-Term Assets | $19.10M | $27.50M | $12.60M |
| YoY Change | 51.59% | 43.98% | 53.66% |
| Inventory | $43.48M | $46.20M | $39.76M |
| Prepaid Expenses | |||
| Receivables | $124.6M | $134.2M | $96.40M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $408.6M | $570.1M | $339.2M |
| YoY Change | 20.47% | 39.53% | 34.07% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $288.4M | $274.5M | $303.0M |
| YoY Change | -4.81% | -4.82% | 218.87% |
| Goodwill | $92.74M | $92.74M | |
| YoY Change | 0.0% | ||
| Intangibles | $576.0M | $617.8M | |
| YoY Change | -6.77% | ||
| Long-Term Investments | $82.80M | $87.80M | $55.70M |
| YoY Change | 48.65% | 6.04% | -40.36% |
| Other Assets | $21.71M | $14.90M | $26.79M |
| YoY Change | -18.98% | -31.34% | 142.25% |
| Total Long-Term Assets | $1.062B | $1.008B | $1.096B |
| YoY Change | -3.13% | -5.11% | 449.44% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $408.6M | $570.1M | $339.2M |
| Total Long-Term Assets | $1.062B | $1.008B | $1.096B |
| Total Assets | $1.470B | $1.578B | $1.435B |
| YoY Change | 2.44% | 7.3% | 217.21% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $18.28M | $19.50M | $18.40M |
| YoY Change | -0.64% | 6.56% | 97.85% |
| Accrued Expenses | $58.60M | $71.70M | $60.80M |
| YoY Change | -3.62% | 22.35% | 70.31% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $6.750M | $6.800M | $3.100M |
| YoY Change | 117.74% | 0.0% | |
| Total Short-Term Liabilities | $85.93M | $100.9M | $89.16M |
| YoY Change | -3.63% | 17.46% | 85.54% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $362.3M | $357.5M | $441.4M |
| YoY Change | -17.92% | -1.32% | |
| Other Long-Term Liabilities | $23.26M | $24.80M | $8.751M |
| YoY Change | 165.8% | -22.74% | 16.12% |
| Total Long-Term Liabilities | $385.5M | $382.3M | $450.1M |
| YoY Change | -14.35% | -3.07% | 5872.81% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $85.93M | $100.9M | $89.16M |
| Total Long-Term Liabilities | $385.5M | $382.3M | $450.1M |
| Total Liabilities | $517.9M | $512.4M | $581.4M |
| YoY Change | -10.91% | -1.06% | 862.05% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$499.9M | -$524.9M | |
| YoY Change | -4.76% | 27.64% | |
| Common Stock | $1.460B | $1.382B | |
| YoY Change | 5.65% | 47.44% | |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | $5.380M | $571.0K | |
| YoY Change | 842.21% | -99.56% | |
| Treasury Stock Shares | 313.5K shares | 35.08K shares | |
| Shareholders Equity | $952.4M | $1.065B | $853.9M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $1.470B | $1.578B | $1.435B |
| YoY Change | 2.44% | 7.3% | 217.21% |
Cashflow Statement
| Concept | 2013 Q1 | 2013 | 2012 Q1 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | $3.000M | $24.98M | -$63.40M |
| YoY Change | -104.73% | -0.07% | 383.97% |
| Depreciation, Depletion And Amortization | $18.32M | $31.90M | $20.60M |
| YoY Change | -11.06% | -33.38% | 724.0% |
| Cash From Operating Activities | $55.40M | $92.20M | $15.30M |
| YoY Change | 262.09% | -27.17% | 84.34% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $8.259M | -$19.10M | -$8.200M |
| YoY Change | -200.72% | -212.43% | 485.71% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | -$103.5M | -$46.30M | -$13.50M |
| YoY Change | 666.67% | 0.87% | 32.35% |
| Cash From Investing Activities | -$111.8M | -$65.40M | -$21.60M |
| YoY Change | 417.59% | -3.96% | 87.83% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | $1.688M | ||
| YoY Change | |||
| Cash From Financing Activities | 17.60M | 43.70M | 4.500M |
| YoY Change | 291.11% | -197.11% | 66.67% |
| NET CHANGE | |||
| Cash From Operating Activities | 55.40M | 92.20M | 15.30M |
| Cash From Investing Activities | -111.8M | -65.40M | -21.60M |
| Cash From Financing Activities | 17.60M | 43.70M | 4.500M |
| Net Change In Cash | -38.80M | 70.50M | -1.800M |
| YoY Change | 2055.56% | 422.22% | 260.0% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | $55.40M | $92.20M | $15.30M |
| Capital Expenditures | $8.259M | -$19.10M | -$8.200M |
| Free Cash Flow | $47.14M | $111.3M | $23.50M |
| YoY Change | 100.6% | 1.54% | 142.27% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2013 | alks |
Minimum Number Of Commercial Drug Products In Portfolio
MinimumNumberOfCommercialDrugProductsInPortfolio
|
20 | product |
| CY2013 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="font-size:10.0pt;font-family:Times New Roman;"> <ul> <li style="list-style: none;"> <p style="FONT-FAMILY: times;"><font size="2"><b><i>Use of Estimates</i></b></font></p></li></ul> <p style="FONT-FAMILY: times;"><font size="2">        The preparation of the Company's consolidated financial statements in accordance with accounting principles generally accepted in the United States ("U.S.") ("GAAP") requires management to make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, the Company evaluates its estimates and judgments and methodologies, including those related to revenue recognition and related allowances, its collaborative relationships, clinical trial expenses, the valuation of inventory, impairment and amortization of intangibles and long-lived assets, share-based compensation, income taxes including the valuation allowance for deferred tax assets, valuation of investments and derivative instruments, litigation and restructuring charges. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions.</font></p> </div> | |
| CY2013 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="font-size:10.0pt;font-family:Times New Roman;"> <ul> <li style="list-style: none;"> <p style="FONT-FAMILY: times;"><font size="2"><b><i>Concentrations</i></b></font></p></li></ul> <p style="FONT-FAMILY: times;"><font size="2">        Financial instruments that potentially subject the Company to concentrations of credit risk are accounts receivable and marketable securities. Billings to large pharmaceutical and biotechnology companies account for the majority of the Company's accounts receivable, and collateral is generally not required from these customers. To mitigate credit risk, the Company monitors the financial performance and credit worthiness of its customers. The following represents revenue and receivables from the Company's customers exceeding 10% of the total in each category as of, and for the years ended, March 31:</font></p> <div style="POSITION: relative; PADDING-BOTTOM: 0pt; PADDING-LEFT: 0pt; WIDTH: 70%; PADDING-RIGHT: 0pt; MARGIN-LEFT: 15%; PADDING-TOP: 0pt;"> <p style="FONT-FAMILY: times;"><font size="2"><!-- COMMAND=ADD_TABLEWIDTH,"100%" --></font></p> <!-- User-specified TAGGED TABLE --> <div align="center"> <table border="0" cellspacing="0" cellpadding="0" width="100%" style="text-align:left;"> <tr style="padding:0;"><!-- TABLE COLUMN WIDTHS SET --> <td style="FONT-FAMILY: times;" align="left"></td> <td style="FONT-FAMILY: times;" width="12"></td> <td style="FONT-FAMILY: times;" width="7" align="right"></td> <td style="FONT-FAMILY: times;" width="54"></td> <td style="FONT-FAMILY: times;" width="12"></td> <td style="FONT-FAMILY: times;" width="7" align="right"></td> <td style="FONT-FAMILY: times;" width="40"></td> <td style="FONT-FAMILY: times;" width="12"></td> <td style="FONT-FAMILY: times;" width="7" align="right"></td> <td style="FONT-FAMILY: times;" width="54"></td> <td style="FONT-FAMILY: times;" width="12"></td> <td style="FONT-FAMILY: times;" width="7" align="right"></td> <td style="FONT-FAMILY: times;" width="40"></td> <td style="FONT-FAMILY: times;" width="12"></td> <td style="FONT-FAMILY: times;" width="7" align="right"></td> <td style="FONT-FAMILY: times;" width="54"></td> <td style="FONT-FAMILY: times;" width="12"></td> <td style="FONT-FAMILY: times;" width="7" align="right"></td> <td style="FONT-FAMILY: times;" width="40"></td> <td style="FONT-FAMILY: times;" width="12"></td><!-- TABLE COLUMN WIDTHS END --></tr> <tr style="padding:0;" valign="bottom"> <th style="FONT-FAMILY: times;" align="left"><font size="2"> </font><br /></th> <th style="FONT-FAMILY: times;"><font size="1"> </font></th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="5" align="center"><font size="1"><b>2013</b></font></th> <th style="FONT-FAMILY: times;"><font size="1"> </font></th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="5" align="center"><font size="1"><b>2012</b></font></th> <th style="FONT-FAMILY: times;"><font size="1"> </font></th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="5" align="center"><font size="1"><b>2011</b></font></th> <th style="FONT-FAMILY: times;"><font size="1"> </font></th></tr> <tr style="padding:0;" valign="bottom"> <th style="FONT-FAMILY: times;" nowrap="nowrap" align="left"> <div style="BORDER-BOTTOM: #000000 1pt solid; WIDTH: 34pt; MARGIN-BOTTOM: 0pt;"><font size="1"><b>Customer <!-- COMMAND=ADD_SCROPPEDRULE,34pt --></b></font></div></th> <th style="FONT-FAMILY: times;"><font size="1"> </font></th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Receivables</b></font></th> <th style="FONT-FAMILY: times;"><font size="1"> </font></th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Revenue</b></font></th> <th style="FONT-FAMILY: times;"><font size="1"> </font></th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Receivables</b></font></th> <th style="FONT-FAMILY: times;"><font size="1"> </font></th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Revenue</b></font></th> <th style="FONT-FAMILY: times;"><font size="1"> </font></th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Receivables</b></font></th> <th style="FONT-FAMILY: times;"><font size="1"> </font></th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times;" colspan="2" align="center"><font size="1"><b>Revenue</b></font></th> <th style="FONT-FAMILY: times;"><font size="1"> </font></th></tr> <tr style="padding:0;" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times;" valign="bottom"> <p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Janssen</font></p></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">32</font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2">%</font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">35</font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2">%</font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">30</font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2">%</font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">48</font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2">%</font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">75</font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2">%</font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">83</font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2">%</font></td></tr> <tr style="padding:0;" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times;" valign="bottom"> <p style="TEXT-INDENT: -10pt; FONT-FAMILY: times; MARGIN-LEFT: 10pt;"><font size="2">Acorda</font></p></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">15</font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2">%</font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">11</font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2">%</font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">11</font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2">%</font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">—</font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">—</font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td> <td style="FONT-FAMILY: times;" valign="bottom" align="right"><font size="2">—</font></td> <td style="FONT-FAMILY: times;" valign="bottom"><font size="2"> </font></td></tr></table></div> <!-- end of user-specified TAGGED TABLE --></div> <p style="FONT-FAMILY: times;"><font size="2">        The Company generally holds its interest-bearing investments with major financial institutions and in accordance with documented investment policies and the Company limits the amount of credit exposure to any one financial institution or corporate issuer. The Company's investment objectives are, first, to assure liquidity and conservation of capital and, second, to obtain investment income.</font></p> </div> | |
| CY2013 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<div style="font-size:10.0pt;font-family:Times New Roman;"> <ul> <li style="list-style: none;"> <p style="FONT-FAMILY: times;"><font size="2"><b><i>Reclassifications</i></b></font></p></li></ul> <p style="FONT-FAMILY: times;"><font size="2">        An amount equal to $45.8 million that was previously classified as "Amortization of acquired intangibles" in the year ended March 31, 2012, has been reclassified to "Impairment of long-lived assets" in the accompanying consolidated statements of operations and comprehensive income (loss) and statement of cash flows to conform to current period presentation.</font></p> <p style="FONT-FAMILY: times;"><font size="2">        Similarly, $3.7 million and $1.4 million that were previously classified as "Proceeds from the issuance of ordinary shares under share-based compensation arrangements" in the years ended March 31, 2012 and 2011, respectively, have been reclassified to "Employee taxes paid related to net share settlement of equity awards" in the accompanying consolidated statements of cash flows to conform to current period presentation.</font></p> </div> | |
| CY2012Q1 | us-gaap |
Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
|
1900000 | USD |
| CY2013Q1 | us-gaap |
Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
|
2000000 | USD |
| CY2011Q1 | us-gaap |
Asset Retirement Obligation
AssetRetirementObligation
|
1692000 | USD |
| CY2012 | us-gaap |
Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
|
170000 | USD |
| CY2012Q1 | us-gaap |
Asset Retirement Obligation
AssetRetirementObligation
|
1862000 | USD |
| CY2013Q1 | us-gaap |
Asset Retirement Obligation
AssetRetirementObligation
|
2049000 | USD |
| CY2013 | us-gaap |
Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
|
187000 | USD |
| CY2013 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
100000 | USD |
| CY2012 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
500000 | USD |
| CY2011 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
0 | USD |
| CY2013 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
1 | segment |
| CY2012Q1 | alks |
Marketable Securities At Amortized Cost
MarketableSecuritiesAtAmortizedCost
|
162352000 | USD |
| CY2012Q1 | alks |
Marketable Securities Gross Unrealized Gains
MarketableSecuritiesGrossUnrealizedGains
|
954000 | USD |
| CY2012Q1 | alks |
Marketable Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses
MarketableSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses
|
109000 | USD |
| CY2012Q1 | alks |
Marketable Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses
MarketableSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses
|
660000 | USD |
| CY2012Q1 | us-gaap |
Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
|
162537000 | USD |
| CY2013Q1 | alks |
Inventory Finished Goods Net Of Reserves Located At Third Party Warehouse And Shipping Service Provider
InventoryFinishedGoodsNetOfReservesLocatedAtThirdPartyWarehouseAndShippingServiceProvider
|
600000 | USD |
| CY2012Q1 | alks |
Inventory Finished Goods Net Of Reserves Located At Third Party Warehouse And Shipping Service Provider
InventoryFinishedGoodsNetOfReservesLocatedAtThirdPartyWarehouseAndShippingServiceProvider
|
1300000 | USD |
| CY2013Q1 | alks |
Marketable Securities At Amortized Cost
MarketableSecuritiesAtAmortizedCost
|
207361000 | USD |
| CY2013Q1 | alks |
Marketable Securities Gross Unrealized Gains
MarketableSecuritiesGrossUnrealizedGains
|
64000 | USD |
| CY2013Q1 | alks |
Marketable Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses
MarketableSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses
|
45000 | USD |
| CY2013Q1 | alks |
Marketable Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses
MarketableSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses
|
162000 | USD |
| CY2013Q1 | us-gaap |
Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
|
207218000 | USD |
| CY2013 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
258937000 | USD |
| CY2013 | alks |
Marketable Securities Realized Gain
MarketableSecuritiesRealizedGain
|
39000 | USD |
| CY2013 | alks |
Marketable Securities Realized Loss
MarketableSecuritiesRealizedLoss
|
5000 | USD |
| CY2012 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
323028000 | USD |
| CY2011 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
385511000 | USD |
| CY2012 | alks |
Marketable Securities Realized Gain
MarketableSecuritiesRealizedGain
|
47000 | USD |
| CY2011 | alks |
Marketable Securities Realized Gain
MarketableSecuritiesRealizedGain
|
77000 | USD |
| CY2012 | alks |
Marketable Securities Realized Loss
MarketableSecuritiesRealizedLoss
|
11000 | USD |
| CY2011 | alks |
Marketable Securities Realized Loss
MarketableSecuritiesRealizedLoss
|
32000 | USD |
| CY2013Q1 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
|
80388000 | USD |
| CY2013Q1 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
|
124572000 | USD |
| CY2013Q1 | us-gaap |
Available For Sale Securities Debt Maturities Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost
|
204960000 | USD |
| CY2013Q1 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
80399000 | USD |
| CY2013Q1 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
124418000 | USD |
| CY2013Q1 | us-gaap |
Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
|
204817000 | USD |
| CY2013Q1 | us-gaap |
Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
|
1200000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-68148000 | USD |
| CY2013Q1 | us-gaap |
Held To Maturity Securities Debt Maturities Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmount
|
1200000 | USD |
| CY2013Q1 | us-gaap |
Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
|
1200000 | USD |
| CY2013Q1 | us-gaap |
Held To Maturity Securities Debt Maturities Fair Value
HeldToMaturitySecuritiesDebtMaturitiesFairValue
|
1200000 | USD |
| CY2012Q1 | us-gaap |
Cost Method Investments Aggregate Carrying Amount
CostMethodInvestmentsAggregateCarryingAmount
|
8700000 | USD |
| CY2013Q1 | us-gaap |
Cost Method Investments Aggregate Carrying Amount
CostMethodInvestmentsAggregateCarryingAmount
|
8700000 | USD |
| CY2012Q4 | us-gaap |
Notes Receivable Gross
NotesReceivableGross
|
1100000 | USD |
| CY2012Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
|
10656000 | USD |
| CY2012Q1 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
12841000 | USD |
| CY2012Q1 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
9569000 | USD |
| CY2012Q1 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
16968000 | USD |
| CY2013Q1 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
16135000 | USD |
| CY2013Q1 | us-gaap |
Inventory Net
InventoryNet
|
43483000 | USD |
| CY2012Q1 | us-gaap |
Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
|
381000 | USD |
| CY2012Q1 | us-gaap |
Inventory Net
InventoryNet
|
39759000 | USD |
| CY2013Q1 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
13506000 | USD |
| CY2013Q1 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
13842000 | USD |
| CY2012Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
416302000 | USD |
| CY2012Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
113307000 | USD |
| CY2012Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
302995000 | USD |
| CY2013Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
122293000 | USD |
| CY2013Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
410728000 | USD |
| CY2013Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
288435000 | USD |
| CY2013 | us-gaap |
Depreciation
Depreciation
|
31900000 | USD |
| CY2012 | us-gaap |
Depreciation
Depreciation
|
22500000 | USD |
| CY2011 | us-gaap |
Depreciation
Depreciation
|
8700000 | USD |
| CY2013Q1 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
640600000 | USD |
| CY2013Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
64607000 | USD |
| CY2013Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
575993000 | USD |
| CY2013Q1 | us-gaap |
Goodwill Gross
GoodwillGross
|
92740000 | USD |
| CY2013Q1 | us-gaap |
Goodwill
Goodwill
|
92740000 | USD |
| CY2013 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
41852000 | USD |
| CY2012 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
25355000 | USD |
| CY2013Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
18282000 | USD |
| CY2013Q1 | us-gaap |
Due To Employees Current
DueToEmployeesCurrent
|
30432000 | USD |
| CY2013Q1 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
970000 | USD |
| CY2013Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
27226000 | USD |
| CY2013Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
76910000 | USD |
| CY2012Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
18400000 | USD |
| CY2012Q1 | us-gaap |
Due To Employees Current
DueToEmployeesCurrent
|
25023000 | USD |
| CY2012Q1 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
2472000 | USD |
| CY2012Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
33259000 | USD |
| CY2012Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
79154000 | USD |
| CY2013 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
24983000 | USD |
| CY2013 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
131713000 | shares |
| CY2013 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
4025000 | shares |
| CY2013 | alks |
Incremental Common Shares Attributable To Other Than Share Based Payment Arrangements
IncrementalCommonSharesAttributableToOtherThanShareBasedPaymentArrangements
|
1362000 | shares |
| CY2013 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
5387000 | shares |
| CY2013 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
137100000 | shares |
| CY2012 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-113678000 | USD |
| CY2011 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-45540000 | USD |
| CY2012 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
114702000 | shares |
| CY2011 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
95610000 | shares |
| CY2012 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
114702000 | shares |
| CY2011 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
95610000 | shares |
| CY2013 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4497000 | shares |
| CY2012 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
9504000 | shares |
| CY2011 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
14293000 | shares |
| CY2011Q3 | us-gaap |
Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
|
215000000 | USD |
| CY2013 | us-gaap |
Stock Repurchase Program Remaining Authorized Repurchase Amount
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount
|
101000000 | USD |
| CY2013Q1 | us-gaap |
Long Term Debt
LongTermDebt
|
369008000 | USD |
| CY2012Q1 | us-gaap |
Long Term Debt
LongTermDebt
|
444460000 | USD |
| CY2013Q1 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
6750000 | USD |
| CY2013Q1 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
362258000 | USD |
| CY2012Q1 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
3100000 | USD |
| CY2012Q1 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
441360000 | USD |
| CY2013Q1 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
3300000 | USD |
| CY2013 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
5800000 | USD |
| CY2012 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
3500000 | USD |
| CY2013 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
34716000 | USD |
| CY2012 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
28826000 | USD |
| CY2011 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
19832000 | USD |
| CY2013 | us-gaap |
Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
|
600000 | USD |
| CY2012 | us-gaap |
Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
|
400000 | USD |
| CY2011 | us-gaap |
Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
|
600000 | USD |
| CY2013 | alks |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans Under Which Awards Are Currently Made
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlansUnderWhichAwardsAreCurrentlyMade
|
2 | item |
| CY2013 | alks |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans Under Which No Further Awards Will Be Made
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlansUnderWhichNoFurtherAwardsWillBeMade
|
5 | item |
| CY2013Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
|
9800000 | shares |
| CY2013 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
Yes | |
| CY2013 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
| CY2013Q1 | dei |
Entity Public Float
EntityPublicFloat
|
2712520116 | USD |
| CY2013Q1 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
3838000 | USD |
| CY2013Q1 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
4068000 | USD |
| CY2013Q1 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
3970000 | USD |
| CY2013Q1 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
3473000 | USD |
| CY2013Q1 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
3650000 | USD |
| CY2013Q1 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
8350000 | USD |
| CY2013Q1 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
27349000 | USD |
| CY2013Q1 | us-gaap |
Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals
OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals
|
1956000 | USD |
| CY2013Q1 | alks |
Operating Leases Future Minimum Payments Due Net Of Sublease
OperatingLeasesFutureMinimumPaymentsDueNetOfSublease
|
25393000 | USD |
| CY2013 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
5000000 | USD |
| CY2013 | us-gaap |
Operating Leases Rent Expense Sublease Rentals1
OperatingLeasesRentExpenseSubleaseRentals1
|
2600000 | USD |
| CY2012 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
4200000 | USD |
| CY2012 | us-gaap |
Operating Leases Rent Expense Sublease Rentals1
OperatingLeasesRentExpenseSubleaseRentals1
|
9200000 | USD |
| CY2011 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
5400000 | USD |
| CY2011 | us-gaap |
Operating Leases Rent Expense Sublease Rentals1
OperatingLeasesRentExpenseSubleaseRentals1
|
7300000 | USD |
| CY2013Q1 | us-gaap |
Significant Purchase Commitment Remaining Minimum Amount Committed
SignificantPurchaseCommitmentRemainingMinimumAmountCommitted
|
76000000 | USD |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.125 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.047 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
0.033 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.280 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
|
0.405 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.295 | pure |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.125 | pure |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
-0.068 | pure |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
-0.007 | pure |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.473 | pure |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
|
-0.517 | pure |
| CY2012 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.006 | pure |
| CY2011 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.021 | pure |
| CY2011 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.301 | pure |
| CY2011 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.340 | pure |
| CY2011 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
|
0.014 | pure |
| CY2011 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
-0.026 | pure |
| CY2011 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
|
1560000 | USD |
| CY2012 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
|
1741000 | USD |
| CY2012 | us-gaap |
Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
|
68000 | USD |
| CY2013 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
|
1065000 | USD |
| CY2010Q1 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
3373000 | USD |
| CY2011Q1 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
4933000 | USD |
| CY2012Q1 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
6606000 | USD |
| CY2013Q1 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
7258000 | USD |
| CY2013Q1 | us-gaap |
Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
|
7200000 | USD |
| CY2013 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
20400000 | USD |
| CY2013Q1 | alks |
Deferred Tax Liability Related To Acquired Intellectual Property
DeferredTaxLiabilityRelatedToAcquiredIntellectualProperty
|
31800000 | USD |
| CY2013Q1 | alks |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Exercise Of Stock Options
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsExerciseOfStockOptions
|
8437000 | USD |
| CY2013Q1 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
23468000 | USD |
| CY2013Q1 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
|
10543000 | USD |
| CY2013Q1 | us-gaap |
Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
|
1682000 | USD |
| CY2013Q1 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
9150000 | USD |
| CY2013Q1 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
86714000 | USD |
| CY2013Q1 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
30868000 | USD |
| CY2013Q1 | us-gaap |
Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
|
40968000 | USD |
| CY2013Q1 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
19607000 | USD |
| CY2013Q1 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
62647000 | USD |
| CY2013Q1 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
-31779000 | USD |
| CY2012Q1 | alks |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Exercise Of Stock Options
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsExerciseOfStockOptions
|
22089000 | USD |
| CY2012Q1 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
21992000 | USD |
| CY2012Q1 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
|
12294000 | USD |
| CY2012Q1 | us-gaap |
Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
|
1778000 | USD |
| CY2012Q1 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
9774000 | USD |
| CY2012Q1 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
107128000 | USD |
| CY2012Q1 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
28763000 | USD |
| CY2012Q1 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
-33892000 | USD |
| CY2012Q1 | us-gaap |
Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
|
43606000 | USD |
| CY2012Q1 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
19049000 | USD |
| CY2012Q1 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
62655000 | USD |
| CY2012Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
83601000 | USD |
| CY2012Q1 | us-gaap |
Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
|
106846000 | USD |
| CY2012Q1 | us-gaap |
Receivables Net Current
ReceivablesNetCurrent
|
96381000 | USD |
| CY2012Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
12566000 | USD |
| CY2012Q1 | us-gaap |
Assets Current
AssetsCurrent
|
339153000 | USD |
| CY2012Q1 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
617845000 | USD |
| CY2012Q1 | us-gaap |
Goodwill
Goodwill
|
92740000 | USD |
| CY2012Q1 | us-gaap |
Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
|
55691000 | USD |
| CY2012Q1 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
26793000 | USD |
| CY2012Q1 | us-gaap |
Assets
Assets
|
1435217000 | USD |
| CY2012Q1 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
6910000 | USD |
| CY2012Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
89164000 | USD |
| CY2012Q1 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
7578000 | USD |
| CY2012Q1 | us-gaap |
Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
|
34512000 | USD |
| CY2012Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
8751000 | USD |
| CY2012Q1 | us-gaap |
Liabilities
Liabilities
|
581365000 | USD |
| CY2013Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2012Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2013Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
USD | |
| CY2012Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
USD | |
| CY2012Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
1300000 | USD |
| CY2012Q1 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
571000 | USD |
| CY2012Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
1380742000 | USD |
| CY2012Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-2713000 | USD |
| CY2012Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-524906000 | USD |
| CY2012Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
853852000 | USD |
| CY2012Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1435217000 | USD |
| CY2011 | us-gaap |
Gain Loss On Non Recourse Debt
GainLossOnNonRecourseDebt
|
-841000 | USD |
| CY2011 | alks |
Payment Of Non Recourse Product Secured Seven Percent Notes Principal Attributable To Original Issue Discount
PaymentOfNonRecourseProductSecuredSevenPercentNotesPrincipalAttributableToOriginalIssueDiscount
|
-6611000 | USD |
| CY2013 | alks |
Nonrecourse Secured Notes Principal
NonrecourseSecuredNotesPrincipal
|
0.07 | pure |
| CY2013Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
952374000 | USD |
| CY2013Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1470291000 | USD |
| CY2013Q1 | us-gaap |
Assets Current
AssetsCurrent
|
408588000 | USD |
| CY2013Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
| CY2012Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
| CY2013Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
| CY2012Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
| CY2013Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2012Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2012Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2013Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2013Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2012Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2013Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
450000000 | shares |
| CY2012Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
450000000 | shares |
| CY2013Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
134065107 | shares |
| CY2012Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
130212530 | shares |
| CY2013Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
133751610 | shares |
| CY2012Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
130177452 | shares |
| CY2013Q1 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
313497 | shares |
| CY2012Q1 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
35078 | shares |
| CY2012 | alks |
Manufacturing And Royalty Revenues
ManufacturingAndRoyaltyRevenues
|
326444000 | USD |
| CY2011 | alks |
Manufacturing And Royalty Revenues
ManufacturingAndRoyaltyRevenues
|
156840000 | USD |
| CY2012 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
41184000 | USD |
| CY2011 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
28920000 | USD |
| CY2012 | us-gaap |
Contracts Revenue
ContractsRevenue
|
22349000 | USD |
| CY2011 | us-gaap |
Contracts Revenue
ContractsRevenue
|
880000 | USD |
| CY2012 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
389977000 | USD |
| CY2011 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
186640000 | USD |
| CY2012 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
127578000 | USD |
| CY2011 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
52185000 | USD |
| CY2012 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
141893000 | USD |
| CY2011 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
97239000 | USD |
| CY2012 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
137632000 | USD |
| CY2011 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
82847000 | USD |
| CY2012 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
478258000 | USD |
| CY2011 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
232271000 | USD |
| CY2012 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-88281000 | USD |
| CY2011 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-45631000 | USD |
| CY2012 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
1516000 | USD |
| CY2011 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
2728000 | USD |
| CY2012 | us-gaap |
Interest Expense
InterestExpense
|
28111000 | USD |
| CY2011 | us-gaap |
Interest Expense
InterestExpense
|
3298000 | USD |
| CY2012 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
484000 | USD |
| CY2011 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-290000 | USD |
| CY2012 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-26111000 | USD |
| CY2011 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-860000 | USD |
| CY2012 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-114392000 | USD |
| CY2011 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-46491000 | USD |
| CY2012 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-714000 | USD |
| CY2011 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-951000 | USD |
| CY2012 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.99 | |
| CY2011 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.48 | |
| CY2012 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.99 | |
| CY2011 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.48 | |
| CY2012 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
627000 | USD |
| CY2011 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
379000 | USD |
| CY2012 | alks |
Nonrecourse Secured Notes Principal
NonrecourseSecuredNotesPrincipal
|
0.07 | pure |
| CY2011 | alks |
Nonrecourse Secured Notes Principal
NonrecourseSecuredNotesPrincipal
|
0.07 | pure |
| CY2012 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-113378000 | USD |
| CY2011 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-45161000 | USD |
| CY2013 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
703000 | USD |
| CY2013 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
25178000 | USD |
| CY2013 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
35441000 | USD |
| CY2013 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-46372000 | USD |
| CY2013 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
81813000 | USD |
| CY2013 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
493735000 | USD |
| CY2013 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
575548000 | USD |
| CY2010Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
412616000 | USD |
| CY2011Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
392018000 | USD |
| CY2012 | us-gaap |
Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax
|
-194000 | USD |
| CY2011 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
|
225000 | USD |
| CY2012 | us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
525074000 | USD |
| CY2011 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
6158000 | USD |
| CY2012 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
20864000 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
34360000 | USD |
| CY2012 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
|
372000 | USD |
| CY2011 | alks |
Receipt Of Company Stock For Purchase Of Stock Options Or To Satisfy Minimum Tax Withholding Obligations Related To Stock Based Awards Value
ReceiptOfCompanyStockForPurchaseOfStockOptionsOrToSatisfyMinimumTaxWithholdingObligationsRelatedToStockBasedAwardsValue
|
-1414000 | USD |
| CY2012 | alks |
Receipt Of Company Stock For Purchase Of Stock Options Or To Satisfy Minimum Tax Withholding Obligations Related To Stock Based Awards Value
ReceiptOfCompanyStockForPurchaseOfStockOptionsOrToSatisfyMinimumTaxWithholdingObligationsRelatedToStockBasedAwardsValue
|
-3676000 | USD |
| CY2011 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
19819000 | USD |
| CY2012 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
28615000 | USD |
| CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
34926000 | USD |
| CY2012 | us-gaap |
Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
|
4335000 | USD |
| CY2011 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
379000 | USD |
| CY2012 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
627000 | USD |
| CY2011 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-45540000 | USD |
| CY2013 | us-gaap |
Net Income Loss
NetIncomeLoss
|
24983000 | USD |
| CY2012 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
28826000 | USD |
| CY2011 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
19832000 | USD |
| CY2012 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
47884000 | USD |
| CY2011 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
8652000 | USD |
| CY2012 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-14556000 | USD |
| CY2013 | us-gaap |
Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
|
8867000 | USD |
| CY2013 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-19670000 | USD |
| CY2013 | alks |
Prepayment Of Penalty On Debt Refinancing
PrepaymentOfPenaltyOnDebtRefinancing
|
6533000 | USD |
| CY2013 | alks |
Payment Of Instrument Principal Attributable To Original Issue Discount
PaymentOfInstrumentPrincipalAttributableToOriginalIssueDiscount
|
2657000 | USD |
| CY2012 | us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
4342000 | USD |
| CY2011 | us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
1861000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
14014000 | USD |
| CY2011 | us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
-2347000 | USD |
| CY2012 | alks |
Increase Decrease In Inventory Prepaid Expenses And Other Assets
IncreaseDecreaseInInventoryPrepaidExpensesAndOtherAssets
|
4879000 | USD |
| CY2011 | alks |
Increase Decrease In Inventory Prepaid Expenses And Other Assets
IncreaseDecreaseInInventoryPrepaidExpensesAndOtherAssets
|
-5211000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
15552000 | USD |
| CY2011 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
6954000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
6068000 | USD |
| CY2011 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
635000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
508000 | USD |
| CY2011 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-88000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
126551000 | USD |
| CY2012 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-2482000 | USD |
| CY2011 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-5906000 | USD |
| CY2012 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
16988000 | USD |
| CY2011 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
9401000 | USD |
| CY2012 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
35000 | USD |
| CY2011 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
395000 | USD |
| CY2012 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
494774000 | USD |
| CY2012 | us-gaap |
Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
|
231000 | USD |
| CY2011 | us-gaap |
Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
|
501000 | USD |
| CY2012 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
228229000 | USD |
| CY2011 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
370375000 | USD |
| CY2011 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
-40653000 | USD |
| CY2012 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-417159000 | USD |
| CY2011 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
5629000 | USD |
| CY2012 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
20864000 | USD |
| CY2011 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
6158000 | USD |
| CY2012 | us-gaap |
Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
|
4335000 | USD |
| CY2012 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
444100000 | USD |
| CY2013 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
4809000 | USD |
| CY2012 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
775000 | USD |
| CY2011 | us-gaap |
Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
|
-45397000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
-45043000 | USD |
| CY2012 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
464848000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
|
13360000 | USD |
| CY2012 | us-gaap |
Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
|
45207000 | USD |
| CY2011 | us-gaap |
Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
|
-40930000 | USD |
| CY2012 | us-gaap |
Interest Paid
InterestPaid
|
21658000 | USD |
| CY2011 | us-gaap |
Interest Paid
InterestPaid
|
1684000 | USD |
| CY2012 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
10068000 | USD |
| CY2011 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
60000 | USD |
| CY2012 | us-gaap |
Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
|
3416000 | USD |
| CY2011 | us-gaap |
Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
|
424000 | USD |
| CY2012 | us-gaap |
Noncash Or Part Noncash Acquisition Investments Acquired1
NoncashOrPartNoncashAcquisitionInvestmentsAcquired1
|
1547000 | USD |
| CY2011 | us-gaap |
Noncash Or Part Noncash Acquisition Investments Acquired1
NoncashOrPartNoncashAcquisitionInvestmentsAcquired1
|
1320000 | USD |
| CY2012 | us-gaap |
Stock Issued1
StockIssued1
|
525074000 | USD |
| CY2010Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
79324000 | USD |
| CY2011Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
38394000 | USD |
| CY2013Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
96961000 | USD |
| CY2013 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="FONT-FAMILY: times;"><font size="2"><b>1. THE COMPANY</b></font></p> <p style="FONT-FAMILY: times;"><font size="2">        Alkermes plc (the "Company") is a fully integrated, global biopharmaceutical company that applies its scientific expertise and proprietary technologies to develop innovative medicines that improve patient outcomes. The Company has a diversified portfolio of more than 20 commercial drug products and a substantial clinical pipeline of product candidates that address central nervous system ("CNS") disorders such as addiction, schizophrenia and depression. Headquartered in Dublin, Ireland, Alkermes plc has a research and development ("R&D") center in Waltham, Massachusetts; R&D and manufacturing facilities in Athlone, Ireland; and manufacturing facilities in Gainesville, Georgia and Wilmington, Ohio.</font></p> <p style="FONT-FAMILY: times;"><font size="2">        On September 16, 2011, the business of Alkermes, Inc. and the drug technologies business ("EDT") of Elan Corporation, plc ("Elan") were combined under the Company (this combination is referred to as the "Business Combination", the "acquisition of EDT" or the "EDT acquisition") in a transaction accounted for as a reverse acquisition with Alkermes, Inc. treated as the accounting acquirer. As a result, the historical financial statements of Alkermes, Inc. are included in the comparative prior periods. Use of the terms such as "us," "we," "our," "Alkermes" or the "Company" is meant to refer to Alkermes plc and its consolidated subsidiaries, except where context makes clear that the time period being referenced is prior to September 16, 2011, in which case such terms shall refer to Alkermes, Inc. and its consolidated subsidiaries. Prior to September 16, 2011, Alkermes, Inc. was an independent pharmaceutical company incorporated in the Commonwealth of Pennsylvania and traded on the NASDAQ Global Select Stock Market under the symbol "ALKS."</font></p> </div> | |
| CY2013Q1 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
2270000 | USD |
| CY2013Q1 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
8866000 | USD |
| CY2012Q3 | us-gaap |
New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Net Revenue
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnNetRevenue
|
1700000 | USD |
| CY2013Q1 | alks |
Sales Returns Reserve For Sales Returns As Percentage Of Sales Revenue Goods Net
SalesReturnsReserveForSalesReturnsAsPercentageOfSalesRevenueGoodsNet
|
0.02 | pure |
| CY2013 | us-gaap |
Revenue Recognition Sales Returns Reserve For Sales Returns
RevenueRecognitionSalesReturnsReserveForSalesReturns
|
3200000 | USD |
| CY2013Q1 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
2600000 | USD |
| CY2012 | alks |
Current State And Local Tax Expense From Transfer Of Intellectual Property
CurrentStateAndLocalTaxExpenseFromTransferOfIntellectualProperty
|
13100000 | USD |
| CY2013 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
10458000 | USD |
| CY2012 | alks |
Income Tax Benefit Recorded Relating To Utilization Of Certain Net Operating Loss Carryforwards
IncomeTaxBenefitRecordedRelatingToUtilizationOfCertainNetOperatingLossCarryforwards
|
4300000 | USD |
| CY2011 | alks |
Deferred Income Tax Benefit Increase In Fair Value Of Securities
DeferredIncomeTaxBenefitIncreaseInFairValueOfSecurities
|
200000 | USD |
| CY2013Q1 | us-gaap |
Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
|
39000000 | USD |
| CY2013 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeTax
|
1030000 | USD |
| CY2013 | alks |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Number Of Investments Transfers From Level2to Level1
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNumberOfInvestmentsTransfersFromLevel2toLevel1
|
0 | item |
| us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | USD |
